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Summary  The  impact  of  psychological  factors  on  somatic  disorders  —  and  vice  versa  —  and
the involvement  of  biological  mechanisms  in  psychic  disorders  have  generated  consid-
erable interest  in  recent  years,  notably  thanks  to  cutting-edge  investigation  techniques
(immunohistochemistry, functional  imaging,  genetics,  etc.).  In  the  ﬁeld  of  psychosomatics,
coronary  heart  disease  (CHD)  is  a  frequent  co-morbidity  of  mental  disorders,  particularly  mood
disorders.  Indeed,  there  is  a  bidirectional  relationship  between  CHD  and  mood  disorders,  with
a strong  co-occurrence  of  the  two  diseases  accompanied  by  a  reciprocal  worsening  of  the  prog-
nosis for  the  two  conditions.  Various  epidemiological  studies  have  shown  that  depression  is  a
psychic risk  factor  for  CHD  and  that  CHD  is  present  in  almost  30%  of  patients  with  affective
disorders.  In  this  review  of  the  literature,  we  tackle  the  crucial  question  of  the  diagnosis  of
depression  during  myocardial  infarction.  This  clinical  approach  is  essential  given  the  undereval-
uation of  this  psychic  problem.  Then,  various  psychological,  biological  and  genetic  arguments
are presented  in  support  of  the  hypothesis  that  various  aetiological  mechanisms  of  the  two  dis-
orders are  partly  shared.  We  ﬁnally  deal  with  the  treatment  of  depression  in  the  context  of  CHD
with its  pharmacological  and  psychological  speciﬁcities.  In  conclusion,  this  review  reiteratesary  approach,  which  is  necessary  to  understand,  diagnose  and  thenthe need  for  a  multidisciplin
treat this  frequent  co-morbid  condition  of  heart  disease  and  depression.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé  L’inﬂuence  de  facteurs  psychologiques  promoteurs  d’affections  somatiques  ainsi  que
réciproquement  l’implication  de  mécanismes  biologiques  dans  les  maladies  psychiques  suscitent
actuellement  un  réel  intérêt,  notamment  grâce  aux  techniques  d’investigation  performantes
(immunohistochimie,  imagerie  fonctionnelle,  génétique,  etc.).  Or  dans  le  domaine  de  la  psy-
chosomatique,  les  maladies  cardiovasculaires  en  general  et  les  affections  coronariennes  plus
particulièrement  représentent  une  fréquente  co-morbidité  des  troubles  mentaux,  notamment
dans les  troubles  de  l’humeur.  En  effet,  coronaropathies  et  troubles  de  l’humeur  entretiennent
des relations  bidirectionnelles  avec  une  forte  co-occurrence  des  deux  pathologies  accompagnée
d’une aggravation  mutuelle  du  pronostic  des  deux  affections.  Divers  travaux  épidémiologiques
démontrent  que  la  dépression  constitue  précisément,  d’une  part,  un  facteur  de  risque  psychique
de coronaropathie  tandis  que,  d’autre  part,  les  pathologies  coronariennes  s’accompagnent  chez
près de  30  %  de  sujets  de  troubles  affectifs.  À  partir  d’une  récente  revue  de  la  littérature,  les
auteurs  abordent  la  question  cruciale  du  diagnostic  de  la  dépression  au  décours  d’un  accident
cardiaque,  approche  clinique  essentielle  du  fait  de  la  sous-évaluation  de  cette  problématique
psychique.  Puis  divers  arguments  psychologiques,  biologiques  et  génétiques  sont  exposés,  sou-
tenant l’hypothèse  de  mécanismes  étiologiques  partiellement  communs  aux  deux  affections.
Enﬁn les  auteurs  s’intéressent  à  l’aspect  thérapeutique  de  la  dépression  dans  un  contexte  de
maladie coronarienne  avec  ses  spéciﬁcités  pharmacologiques  et  psychologiques.  En  conclusion
cette revue  rappelle  la  nécessaire  collaboration  transdisciplinaire  nécessaire  à  la  compréhen-
sion, au  diagnostic,  puis  au  traitement  de  la  fréquente  comorbidité  cardiaque  et  dépressive.
© 2013  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Background
he  supposed  links  between  affections  of  the  mind  and
he  body  have  given  rise  to  many  questions  and  debates.
he  ﬁeld  of  psychosomatics  may  shed  light  on  the  impact
f  psychic  equilibrium  on  the  psychodynamic  and  biologi-
al  aspects  of  physical  health.  This  discipline  explores  the
easurable  organic  consequences  of  psychological  factors
n  the  aetiology.  For  example,  the  stress  reaction  expe-
ienced  by  a  subject  exposed  to  a  stressful  environment
s  a  model  of  a  psychosomatic  phenomenon.  This  nor-
al  adaptive  response  to  stress  may  sometimes  become
xcessively  intense  or  excessively  long  and  trigger  phys-
ological  modiﬁcations  that  are  harmful  for  the  body.  In
he  ﬁeld  of  somatic  disease,  could  the  fact  of  develop-
ng  a  depressive  state,  which  is  a  major  factor  of  stress,
ead  to  physiopathological  alterations  at  the  origin  of  heart
isorders?  Today,  although  the  precise  nature  of  the  links
etween  depression  and  coronary  heart  disease  (CHD)  has
ot  yet  been  clearly  established,  these  links  are  being
ighlighted  more  and  more  frequently,  ﬁrst  of  all  from
n  epidemiological  point  of  view  and  then  with  regard  to
he  aetiological  and  clinical  aspects  in  patients  with  this
orrying  co-morbidity.  In  addition,  for  many  years,  the  psy-
hosomatic  approach  has  led  to  better  understanding  of  the
idirectional  impact  of  emotional  disorders  on  cardiac  dis-
ase  and  vice  versa.  Different  studies  have  underlined  the
mpact  of  certain  psychic  dimensions  in  heart  disease,  in
articular  the  importance  of  depression,  which  is  frequently
iscovered  in  patients  with  coronary  artery  disease.  Sur-
risingly,  despite  progress  in  theoretical  knowledge  on  this
ssue,  detecting  an  episode  of  depression  in  patients  with  a
eart  condition  is  not  always  easy  for  the  clinician.  We  tackle
ere  all  of  the  epidemiological  aspects  of  the  links  between
epression  and  CHD;  we  also  cover  the  clinical  speciﬁcities
b
a
C
ef  an  episode  of  depression  in  patients  with  CHD  and  we
resent  the  principal  aetiological  mechanisms  revealed  to
ate,  before  dealing  with  the  different  management  strate-
ies  for  depression  in  patients  with  CHD.
HD and depression: epidemiology of a
o-morbidity
he  signiﬁcant  prevalence  of  depression  in  cardiovascular
isease  in  general  and  coronary  artery  disease  in  particu-
ar  is  a  frequent  phenomenon  [1].  Several  studies  (Table  1)
ave  shown  a  rather  high  incidence  of  episodes  of  depres-
ion,  characterized  by  the  Diagnostic  and  Statistical  Manual
f  Mental  Disorders,  4th  Edition,  Text  Revision  (DSM-IV-TR)
riteria,  ranging  from  15%  to  30%  in  the  aftermath  of  a  coro-
ary  event.  These  ﬁgures  need  to  be  compared  with  the
ean  annual  prevalence  of  episodes  of  depression  in  the
opulation  at  large,  which  is  about  7%.
In  a  bidirectional  manner,  depression  is  an  independent
isk  factor  of  cardiovascular  co-morbidity  [2].  Compared
ith  the  population  at  large,  people  with  characterized
epression  frequently  develop  cardiovascular  disease  due
o  psychological,  behavioural  and  biological  mechanisms.
he  multicentre  INTERHEART  study  reported  the  impact
f  psychic  disease  on  coronary  artery  disease  and  the
mportance  of  psychosocial  stress  (a  notion  that  includes
epression),  which  puts  it  in  third  place  in  the  league
able  of  risk  factors  (with  an  odds  ratio  of  2.67)  for  devel-
ping  cardiovascular  disease  [3],  after  the  apolipoprotein
/apolipoprotein  A1  ratio  and  smoking  but  in  front  of  dia-
etes,  arterial  hypertension  and  abdominal  obesity.  Intense
nd  chronic  stress  lead  to  anxiety  or  depression  disorders.
onsequently,  a  certain  number  of  patients  with  heart  dis-
ase  had  experienced  mood  disorders  beforehand,  whereas
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Table  1  Prevalence  of  depression  in  coronary  heart  disease.
Published  studies  Number  of
subjects
Mean  age
(years)
Symptoms  of
depression  (%)
Depression  characterized
by  DSM  IV-TR  criteria  (%)
Myers  et  al.,  2012  [5] 632  52  27.8  NA
Davidson  et  al.,  2010  [47]  453  25—93  24.0  17.0
Ziegelstein  et  al.,  2000  [48]  204  60  17.2  15.2
Frasure-Smith  et  al.,  1995  [4] 222 60  30.6  16.0
DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision; NA: not available.
ﬁ
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rothers  developed  heart  disease  and  the  episode  of  depres-
sion  occurred  during  the  evolution  of  their  disorder;  these
epidemiological  aspects  thus  justify  speciﬁc  attention.
In  addition,  major  depression  worsens  the  cardiovascu-
lar  prognosis,  particularly  for  coronary  artery  disease,  by
signiﬁcantly  increasing  the  risk  of  recurrent  coronary  artery
disease.  The  relative  risk  of  death  in  depressed  patients  dur-
ing  the  18  months  following  the  cardiac  event  is  twice  that  in
non-depressed  patients  [4].  Recent  studies  have  also  shown
the  harmful  nature  of  depression  after  myocardial  infarc-
tion  in  terms  of  rehospitalization  and  of  greater  difﬁculty  in
stopping  smoking  or  getting  access  to  cardiac  rehabilitation,
which  is  particularly  beneﬁcial  in  this  context  [5].
All  of  these  epidemiological  aspects  underline  the  fre-
quent  co-occurrence  of  depression  and  heart  disease  and
clinicians  should  investigate  the  presence  of  depression  in
patients  with  heart  disease.
Depression in CHD patients: speciﬁc
clinical aspects
The  diagnosis  of  an  episode  of  characterized  depression  in
the  context  of  CHD  remains  a  complex  question,  requiring  a
speciﬁc  approach  from  the  clinician,  who  often  focuses  on
the  somatic  environment  and  does  not  spontaneously  con-
sider  a  psychiatric  approach.  Given  the  sometimes  sudden
onset  of  a  cardiovascular  event,  the  normal  psychological
reaction  to  disease  requires  the  patient  to  adapt,  which
leads  to  a  certain  physiological  depression  in  mood,  the
time  to  come  to  terms  with  the  possible  loss  related  to
the  disease  and  the  sometimes  very  much  changed  future
prospects  for  life.  Usually,  the  potential  problems  due  to
adaptation  should  resolve  in  a  few  weeks  with  no  ampliﬁca-
tion  of  thymic  phenomena.  In  certain  cases,  patients  fail  to
recover  their  normal  mood  to  such  a  degree  that  authentic
depression  progressively  develops.  The  diagnosis  will  be  rel-
atively  easy  if  this  state  of  characterized  depression  takes
on  a  classical  clinical  presentation,  combining  over  several
weeks  the  three  key  elements  of  sadness,  ideomotor  slowing
and  somatic  signs  (modiﬁcation  in  sleep  and  appetite,  the
existence  of  various  functional  disorders).  Nonetheless,  the
clinical  picture  is  often  incomplete:  ﬁrst  of  all,  the  patient
is  particularly  preoccupied  by  the  somatic  aspects  of  the
heart  condition  and  cannot  think  about  a  psychic  problem
that  he  was  probably  unaware  of;  and  then  the  symptoms  of
depression  develop  insidiously,  in  an  almost  masked  form,
essentially  appearing  as  extreme  fatigue,  which  makes  it  dif-
l
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rcult  to  return  to  the  previous  state  [6].  It  therefore  seems
mportant  to  adopt  a  dimensional  analysis  of  the  depression
y  seeking  the  circadian  component,  with  increased  sadness
n  the  morning,  the  absence  of  vitality  or  simply  asthe-
ia,  accompanied  by  a  substantial  improvement  in  these
ymptoms  at  the  end  of  the  day.  Indeed,  these  semiologi-
al  circadian  variations  may  be  the  only  signs  that  suggest  a
iagnosis  of  depression.  In  the  same  way,  particular  atten-
ion  should  be  paid  to  sleep  with  regard  to  both  quality
nd  quantity,  as  depression  is  almost  systematically  accom-
anied  by  sleep  disorders:  insomnia  in  80%  of  cases  and
ypersomnia  more  rarely.  Although  depression  is  sometimes
ifﬁcult  to  identify,  cardiologists  and  general  practitioners
ust  be  encouraged  to  seek  expert  advice  in  cases  of  doubt
bout  the  diagnosis.  Clinicians  must  really  bear  in  mind  the
otential  severity  of  this  co-morbid  association,  as  it  very
eriously  worsens  the  prognosis  in  terms  of  suicide.  A  recent
tudy  showed  that  women  in  particular  showed  a  signiﬁ-
antly  greater  risk  of  suicide  in  depression  associated  with
oronary  artery  disease  [7].  In  order  to  optimize  screening
or  affective  disorders,  certain  cardiology  or  cardiac  reha-
ilitation  units  routinely  use  standard  self-questionnaires,
uch  as  the  Hospital  Anxiety  and  Depression  scale  [8],  which
ive  an  overall  idea  of  the  severity  of  the  anxiodepressive
pisodes  sometimes  found  in  patients  with  heart  disease;
bviously,  these  questionnaires  do  not  replace  the  clinical
nterview  and  are  not  standardized  automatic  providers  of
sychiatric  diagnoses  but  they  do  reveal  certain  emotional
isorders  and  may  conﬁrm  a  clinical  impression  or  simply
acilitate  discussions  between  the  doctor  and  the  patient
n  this  very  sensitive  issue  of  depression  in  the  wake  of  a
ardiac  event.  As  the  epidemiological  and  clinical  reality
f  depression  during  a  cardiac  event  is  now  accepted,  the
ature  of  the  aetiological  links  between  depression  and  CHD
eeds  to  be  considered  from  a  psychological,  behavioural
nd  even  biological  point  of  view.
resumed common mechanisms shared by
epression and CHD
he impact of stress
rom  a  psychological  point  of  view,  several  authors  have
aised  the  question  of  the  role  of  stress  factors  and  the
evel  of  adaptation  to  stressful  stimuli.  Indeed,  the  way  in
hich  a  factor  of  stress  is  ﬁrst  perceived  and  then  managed
onditions  not  only  the  cognitive,  behavioural  and  emotional
esponses  but  also  the  neurohumoral  response,  leading  to
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iological  reactions  likely,  in  the  long  term,  to  tire  the  body
nd  foster  the  onset  of  cardiovascular  disease  or  to  acceler-
te  its  evolution  [9].  The  type  A  personality  proﬁle  deﬁned  in
he  1960s  illustrates  quite  well  the  psychosomatic  transition
rom  a  psychosocial  phenomenon  to  biological  consequences
10].  This  type  A  personality  brings  together  three  criteria:
ntense  activity,  a  desire  to  do  things  quickly  and  combative-
ess  that  may  lead  to  hostile  attitudes  in  order  to  reach  ﬁxed
bjectives.  Several  studies  have  shown  that  people  with
his  type  of  personality  are  more  likely  to  develop  coronary
rtery  disease  [11,12].  In  addition,  the  behaviour  pattern
f  type  A  people  confers  great  vulnerability  to  depression,
hich  Consoli  et  al.  [13]  considered  one  explanation  for
he  very  high  risk  of  heart  disease  in  these  subjects.  Many
ictims  of  myocardial  infarction  have  this  type  of  personal-
ty  or  something  very  similar,  which  destabilizes  them  with
egard  to  both  the  heart  and  the  thymus.  In  addition,  cer-
ain  factors  of  stress  may  require  radical  adaptation,  which
ay  be  costly  from  a  psychosomatic  point  of  view.  Such  fac-
ors  include  losses  (mourning,  retirement,  unemployment)
r  painful  socioprofessional  situations  (social  isolation,  lack
f  recognition  at  work).  Indeed,  several  studies  have  shown
hat  these  events,  which  have  a  strong  emotional  compo-
ent  and  are  likely  to  lead  to  mood  disorders,  are  able  to
rigger  an  adverse  coronary  event  [14].
ehavioural and psychological features
esides  the  inﬂuence  of  psychological  factors,  it  seems  nec-
ssary  to  underline  the  behavioural  impact  of  depression
n  the  negative  evolution  of  heart  disease.  Indeed  mood
isorders  are  sometimes  the  cause  of  psychobehavioural  dis-
urbances,  such  as  a  loss  of  interest  in  carrying  out  simple
asks  (meals,  physical  activity),  which  explains  the  poor
ifestyle  habits  of  depressed  patients,  who  cannot  sum-
on  up  enough  energy  or  motivation  to  consider  stopping
moking,  changing  to  a  well-balanced  diet  or  maintain-
ng  regular  physical  activity  [15]. Depression  may  occur
t  any  time  during  a  person’s  history  of  coronary  artery
isease  and  is  a  behavioural  factor  in  the  development
r  aggravation  of  heart  disease  as  the  patient  adopts  a
rolonged  sedentary  lifestyle,  experiences  a  decline  in
sychological  and  physical  motivation  and  tends  not  to
espect  the  therapeutic  regimen.  To  underline  the  impact
f  behavioural  disturbances,  we  can  quote  the  study
f  Raikkonen  et  al.,  who  showed  that  depressive  symp-
oms  may  be  a  predictive  factor  for  the  development  of
etabolic  syndrome,  especially  among  middle-aged  women
16]; metabolic  disturbances  then  contribute  to  the  onset  of
HD.
mpact on rhythm: a decrease in heart rate
ariability
eart  rate  variability  has  generated  considerable  interest
nd  several  studies  have  investigated  the  physiopathol-
gy  of  links  between  depression  and  heart  disease.  Heart
ate  variability  (HRV)  indicates  the  level  of  homeo-
tasis  between  the  sympathetic  and  parasympathetic
ystems  in  the  regulation  of  the  heart  rate  and  involves
everal  cholinergic  and  monoaminergic  neurotransmitters
10].  HRV  is  an  important  indicator  of  prognosis  in  the  wake
o
bJ.-C.  Chauvet-Gélinier  et  al.
f  myocardial  infarction,  in  the  same  way  as  age,  left-
entricular  ejection  fraction  or  the  frequency  of  arrhythmia.
 decrease  in  heart  rate  variability  is  pathological,  as  shown
y  the  increased  risk  of  sudden  postinfarction  death  in
atients  with  reduced  HRV.  This  reduction  in  HRV  was  also
ore  often  found  in  depressed  patients  than  in  control
ubjects  [17]. This  suggests  that  decreased  HRV  exposes
atients  with  simultaneous  coronary  artery  disease  and
ajor  depression  to  ventricular  arrhythmia  and  excess
ortality.
nﬂammation, oxidative stress and activation
f the HPA axis in depression and cardiac
o-morbidities
he  inﬂammatory  hypothesis  as  a  common  physiopatholo-
ical  pathway  in  mood  disorders  and  cardiovascular  disease
s  being  put  forward  more  and  more  frequently.  Indeed,
y  carefully  examining  the  biological  phenomena  encoun-
ered  in  heart  disease  and  depression,  similar  consequences
eem  to  occur  in  both,  in  particular  a  major  inﬂam-
atory  reaction  [18]  and  oxidative  stress.  Among  the
iological  mechanisms  described  in  the  physiopathology
f  depression,  the  inﬂammatory  hypothesis  is  becom-
ng  more  and  more  solid.  Increased  concentrations  of
lood  markers  of  inﬂammation  (interleukin-1,  interleukin-
,  tumour  necrosis  factor-alpha)  [19,20]  have  been  found
n  both  depression  and  heart  disease.  A  parallel  decrease
n  serum  concentrations  of  omega-3-type  polyunsaturated
atty  acids  with  anti-inﬂammatory  properties  has  also
een  observed  in  depression  and  cardiovascular  disease
21].
Actually,  oxidative  stress  related  to  inﬂammatory
henomena  is  frequently  described  in  most  psychiatric  disor-
ers,  with  increased  membrane  lipid  peroxidation  mediated
y  reactive  oxygen  species  (ROS).  These  damaging  ROS
re  generated  through  both  aerobic  metabolic  physiologi-
al  processes  and  physiopathological  processes,  which  may
e  ischaemic,  inﬂammatory  or  caused  by  psychological
tress  due  to  depression,  for  example.  The  hypothesis
hat  inﬂammatory  and  oxidative  stress  are  factors  in  both
ood  disorders  and  CHD  seems  to  be  growing  stronger
22].
Furthermore,  cardiovascular  co-morbidities  of  affective
isorders  are  usually  associated  with  hyperactivation  of
he  hypothalamohypophysoadrenal  (HPA)  axis.  During  an
pisode  of  characterized  depression,  which  in  itself  is  a
ajor  factor  of  stress,  the  HPA  axis  is  strongly  activated;
n  increase  in  serum  concentrations  of  cortisol  urinary
erivatives  indicate  the  initiation  of  anti-inﬂammatory  pro-
esses  that  try  to  restore  the  disturbed  homeostasis.  This
hronic  hypercortisolaemia  could  induce  glucid  and  lipid
etabolism,  leading  to  increased  amounts  of  visceral  fat
nd  insulin  resistance,  both  of  which  contribute  to  the
evelopment  of  metabolic  syndrome  through  the  activa-
ion  of  proinﬂammatory  mediators  [23]. The  stimulation  of
he  HPA  axis  could  thus  correlate  with  the  development
f  atherosclerosis  and  show  another  biological  similarity
etween  mood  disorders  and  CHD  [10].
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Sympathetic hyperactivity and disturbances in
platelet reactivity
Studies  have  revealed  an  increase  in  plasma  concentra-
tions  of  noradrenaline  [24]  during  episodes  of  characterized
depression,  in  the  same  way  that  clinical  observations  show
a  faster  heart  rate  in  depressed  subjects  than  in  control
subjects.  This  excessive  stimulation  of  the  sympathetic  sys-
tem  develops  and  aggravates  coronary  artery  disease  via
a  double  deleterious  effect  on  heart  function  itself  and
on  platelet  aggregation,  which  is  diminished.  The  harmful
effect  of  depression  on  coronary  artery  disease  could  also
be  due  to  dysfunction  of  the  platelet  system.  Platelets  con-
tain  serotonin  receptors  and  play  a  role  in  both  haemostasis
and  coronary  vasoconstriction  via  this  monoamine;  platelet
hyperactivation  encountered  in  depression  could  thus  lead
to  an  increased  coronary  risk  or  amplify  the  pathology
once  present  by  promoting  ischaemic  mechanisms  [25].
The  sympathetic  pathway  could  therefore  contribute  to  the
development  of  heart  disease  in  depressed  patients  with-
out  heart  disease  and  worsen  the  cardiovascular  prognosis
in  patients  already  weakened  by  coronary  artery  disease.
Genetic markers of vulnerability to depression
and cardiovascular disease
Several  authors  have  shown  that  depression  and  car-
diovascular  disease  share  common  genetic  mechanisms,
particularly  with  regard  to  inﬂammation  pathways  and
oxidative  stress.  For  example,  it  has  been  shown  that  the
length  of  telomeres  (genetic  markers  of  oxidative  stress,
that  trigger  cell  death  when  the  length  reaches  a  critical
threshold)  measured  in  circulating  leukocytes  diminishes  in
both  major  depression  and  coronary  artery  disease,  illus-
trating  in  both  cases  the  impact  of  oxidative  stress  at  the
initial  level  of  the  genetic  machinery  [26,27].  In  unipolar
depression,  Teyssier  et  al.  demonstrated  a  strong  correla-
tion  between  the  leukocyte  expression  of  two  candidate
genes  (p16INK4a and  STMN1,  which  are  biomarkers  of  human
aging  and  telomere  dysfunction)  and  the  depression  scores
in  depressed  patients  and  controls,  sustaining  the  hypoth-
esis  of  shared  fundamental  mechanisms  in  psychiatric  and
somatic  diseases,  particularly  metabolic  and  cardiovascular
diseases  [28]. In  addition,  a  recent  study  has  shown  that  the
omega-3  fatty  acid  synthesis  pathway  is  impaired  in  char-
acterized  depression,  with  a  fall  in  the  expression  of  the
candidate  genes  for  this  metabolic  pathway,  showing  dis-
turbances  in  the  synthesis  of  these  anti-inﬂammatory  and
cardioprotective  fatty  acids  [29]. Moreover,  it  seems  that
these  two  diseases  share  another  genetic  vulnerability  that
could  modulate  their  development.  In  a  study  of  977  patients
with  cardiopathy,  McCaffery  et  al.  revealed  the  inﬂuence
of  a  single  nucleotide  polymorphism  in  the  gene  coding  for
Willebrand  factor  in  the  onset  of  depression  secondary  to
heart  disease  [30]. These  data  should  be  considered  along
with  the  inﬂammation  mechanisms,  endothelial  dysfunction
or  even  altered  platelet  aggregation  mentioned  above  but
conﬁrmed  by  genetic  arguments  showing  physiopathological
links  that  could  lead  to  depression  in  heart  disease  and
vice  versa.  In  addition,  in  a  genetic  study  in  30,000  twins,
Kendler  et  al.  showed  the  rather  marked  impact  of  coronary
t
s
p
r107
rtery  disease  on  the  onset  of  major  depression  [31]. Using
he  results  of  the  Wellcome  Trust  Case  Control  Consortium
WTCCC)  genome-wide  association  study,  Torkamani  et  al.
nalysed  the  genetic  relationships  between  seven  diseases
nd  showed  signiﬁcant  robust  correlations  between  bipo-
ar  disorders,  diabetes  type  2  and  CHD  [32]. There  is  thus
 recent  accumulation  of  genetic  arguments  that  illustrate
he  mechanisms  presumably  shared  by  mood  disorders  and
HD.
he disturbance of circadian rhythms
linicians  and  researchers  are  showing  an  interest  in  the
tudy  of  rhythms  in  mood  disorders;  particularly  the  effect
f  circadian  rhythms  on  depression  [33]. Indeed,  the  clin-
cal  presentation  of  characterized  depression  is  not  linear
ut  often  follows  the  circadian  cycle,  from  classical  morning
adness  to  improved  mood  in  the  evening,  without  forget-
ing  disturbances  in  the  sleep-waking  cycle  that  are  an
lmost  consistent  ﬁnding  and,  from  a  biological  point  of
iew,  alterations  in  the  secretion  of  biochemical  mediators
cortisol,  thyroid-stimulating,  melatonin,  etc.).  The  thera-
eutic  manipulation  of  these  rhythms  thanks  to  light  therapy
r  even  sleep  deprivation  in  certain  clinical  situations  bears
itness  to  the  reality  of  this  concept  in  depression.  Several
tudies  have  shown  different  alterations  in  these  rhythms
haracterized  by  advanced  stages  of  clinical  and  biologi-
al  phenomena  (shorter  latency  to  the  onset  of  paradoxical
leep,  early  secretion  of  cortisol  and  melatonin).  Currently,
he  theoretical  model  of  the  inﬂuence  of  circadian  rhythms
n  the  development  of  episodes  of  depression  still  seems
mperfect  and  brings  together  extremely  complex  genetic,
eurobiological  and  endocrinological  variables.  Here  again,
oncerning  this  issue,  there  seems  to  be  a  group  of  sim-
lar  phenomena  in  depression  and  heart  disease.  Adverse
oronary  events  often  seem  to  follow  a  circadian  cycle,
ith  a  greater  frequency  of  events  in  the  early  morning
34]. Various  hypotheses  have  been  put  forward,  includ-
ng  the  inﬂuence  of  the  genetic  internal  clock,  which  is
f  paramount  importance,  as  is  the  case  with  mood  dis-
rders  [35]. Various  fundamental  studies  have  shown  that
any  of  the  genes  involved  in  heart  and  aorta  function  have
 circadian  expression  [36]  and  that  disturbances  in  cir-
adian  rhythms  cause  histopathological  modiﬁcations  with
brosis  in  animals.  Finally,  one  team  also  demonstrated  in
‘cardiomyopathic’’  Syrian  hamsters  that  a decrease  in  the
mplitude  of  central  temperature  variations  was  predictive
f  death  8  weeks  later  [37], which  illustrates  the  impact
f  circadian  dysregulation  on  heart  function.  Although  it  is
mpossible  to  establish  absolute  links  between  cardiovascu-
ar  disease  and  depression  via  a  dysfunctioning  circadian
ystem,  it  is  well  known  that  circadian  desynchronization
eads  to  both  affective  disorders  and  cardiac  complications.
n  addition,  the  management  of  somatic  or  psychic  disor-
ers  using  an  approach  involving  rhythms  has  the  advantage
f  being  a  global  approach.  This  endorses  educational  ther-
pies  based  on  promoting  a  balance  between  the  biological
nd  social  life  (healthy  sleeping  pattern,  balanced  alterna-
ion  between  work,  physical  activity,  leisure,  etc.),  These
trategies  to  ﬁght  against  decompensated  stress  have  been
roved  to  be  beneﬁcial  in  both  the  somatic  and  psychological
ealms.
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All  of  these  psychological,  behavioural  and  physiopatho-
ogical  arguments  that  link  depression  and  heart  disease  in
 reciprocal  manner  should  lead  clinicians  to  pay  careful
ttention  to  the  psychic  symptoms  of  patients  with  CHD,  in
rder  to  identify  possible  constituted  affective  disorders  and
o  determine  the  appropriate  therapeutic  strategies.
herapeutic strategies
lthough  the  scientiﬁc  arguments  in  favour  of  the  many
inks  between  depression  and  cardiovascular  disease  are
ccumulating,  depression  is  still  ‘‘underdiagnosed’’  in  this
peciﬁc  somatic  context  because  of  insufﬁcient  therapeu-
ic  options.  Concerning  the  pharmacological  treatment  of
epression,  tricyclic  antidepressants,  which  cause  poten-
ially  dangerous  adverse  effects  (rhythm  disorders),  are  no
onger  the  molecules  of  choice  in  this  context.  Several  stud-
es  have  shown  that  the  new  generation  of  antidepressants,
n  particular  selective  serotonin  reuptake  inhibitors,  are
ell  tolerated,  have  a  satisfactory  efﬁcacy-tolerance  proﬁle
nd  are  easy  to  use  in  patients  with  cardiovascular  disease.
n  addition,  these  molecules  show  clinical  efﬁcacy,  acting
n  physiopathological  elements  by  improving  endothelial
unction  while  reducing  the  concentration  of  inﬂammation
arkers  (C-reactive  protein,  interleukin-6)  [38]. In  the  same
ay,  a  meta-analysis  by  Mazza  et  al.  showed  that  selec-
ive  serotonin  reuptake  inhibitors  used  in  the  wake  of  an
cute  coronary  syndrome  led  to  fewer  rehospitalizations
39]. It  therefore  appears  important  to  underline  the  fact
hat  antidepressants  should  be  prescribed  for  a  minimum
f  6  months  in  the  ﬁrst  episode  of  depression;  this  period
an  be  extended  in  cases  of  recurrent  episodes.  Concerning
he  precautions  of  use,  despite  the  remarkable  acceptability
f  this  new  generation  of  antidepressants,  particular  atten-
ion  must  be  paid  to  potential  drug  interactions  between
ntidepressants  and  cardiovascular  drugs,  without  forget-
ing  to  observe  the  metabolic  pathways  passing  through
450  cytochromes;  it  is  also  necessary  to  take  account  of
he  potential  lengthening  of  the  QT  interval  on  the  electro-
ardiogram  for  certain  molecules  [40]. As  a  complement  to
he  pharmacological  treatment,  any  form  of  psychotherapy
eems  beneﬁcial  in  that  it  allows  the  patient  to  speak  to
n  attentive  listener.  However,  in  the  scientiﬁc  literature,
nly  cognitive  behavioural-type  therapies  have  been  eval-
ated  in  a  standardized  manner  and  have  been  shown  to
e  of  interest  in  heart  disease.  These  pragmatic  techniques
or  psychological  support,  which  show  a  beneﬁcial  effect
ather  quickly,  provide  relevant  help  in  stress  management;
n  this  subject,  various  studies  have  shown  that  a  reduc-
ion  in  psychosocial  stress  could  increase  life  expectancy
fter  coronary  artery  bypass  graft  in  victims  of  myocardial
nfarction  [41]. Whatever  the  method  employed,  consider-
te  empathy  can  certainly  help  the  patient  through  possible
eorganization  of  his/her  existence  and  the  frequent  modiﬁ-
ations  in  lifestyle,  which  are  sometimes  radical  and  difﬁcult
o  accept  (smoking  cessation,  diet  changes,  recondition-
ng  to  physical  effort).  These  involve  helping  the  patient
o  preserve  the  positive  dynamic  traits  of  his/her  function-
ng  while  modifying  in  parallel  the  potentially  dangerous
egative  aspects  for  the  heart  such  as  hostility,  exces-
ive  pessimism  or  any  attitude  likely  to  trigger  a  harmfulJ.-C.  Chauvet-Gélinier  et  al.
sychobiological  response  to  different  factors  of  stress.  It
as  thus  shown  that  reducing  inappropriate  responses  to
actors  of  stress  led  to  beneﬁcial  effects  for  both  the  heart
nd  the  psychological  state  [42]. Follow-up  as  an  outpa-
ient  in  a  cardiac  rehabilitation  unit  is  an  excellent  way
or  patients  to  recover  physical  and  psychic  equilibrium  by
etter  understanding  of  their  heart  function,  progressive
econditioning  to  effort,  gradually  learning  the  new  rules  for
ygiene  and  diet  and  gaining  access  to  professionals  in  psy-
hological  care  [43,44]. Finally,  particular  attention  should
e  paid  to  coronary  patients  with  characterized  depression
ho  do  not  respond  to  medical  treatments  and  psychother-
py,  as  several  clinical  trials  have  shown  that  resistance
o  treatment  for  depression  is  a  risk  factor  for  recurrent
ardiovascular  events  and  subsequent  death  [45,46].
onclusion
ffective  disorders  in  general  and  depression  in  particu-
ar  are  multifactorial  conditions  among  which  the  somatic
spect  is  receiving  more  and  more  attention.  Indeed,  recent
tudies  on  mood  disorders  have  conﬁrmed  the  reality  of  a
isease  that  affects  the  brain  and  the  whole  body  via  fun-
amental  multidimensional  processes  that  cause  metabolic
r  cardiovascular  diseases  in  particular  [18]. We  can  there-
ore  underline  the  fact  that  bidirectional  epidemiological,
iological  and  genetic  phenomena  closely  concern  the
elationships  between  CHD  and  depression.  These  intercon-
ected  physiopathological  events  seen  in  both  diseases  bring
upport  to  the  hypothesis  that  these  two  diseases  partially
hare  common  mechanisms  and  lead  us  to  focus  our  atten-
ion  on  the  psychosomatic  dimension.  While  medicine  is
eing  ceaselessly  enriched  with  more  and  more  effective
echnologies,  the  impact  of  psychological  factors  on  the  gen-
sis,  evolution  and  treatment  of  cardiovascular  disease  is
stablishing  itself  as  a  crucial  element  that  should  always  be
onsidered.  And,  whatever  the  aetiology,  it  clearly  appears
hat  depression  darkens  the  prognosis  in  CHD  and  certainly
equires  a  multidisciplinary  approach  so  that  the  depressive
o-morbidities  of  CHD  can  be  diagnosed  and  then  treated.
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